logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

Yusuf A Hannun

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Duke University. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yusuf A Hannun. Retrieved from https://idiyas.com/inventor/yusuf-a-hannun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 224(Granted Patents)


Location History:

  • Durham, NC (US) (1989 - 1990)
  • Chapel Hill, NC (US) (1994 - 1998)

Company Filing History:

goldMedal5 out of 2,084 
 
Duke University
 patents

Years Active: 1989-1998

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5851782 - Inhibitors of ceramidase (1998-12-22),
2. 5830916 - Inhibitor of ceramidase (1998-11-03),
3. 5369030 - Method of inducing cellular differentiations and altering cell phenotype (1994-11-29),
4. 4937232 - Inhibition of protein kinase C by long-chain bases (1990-06-26),
5. 4816450 - Inhibition of protein kinase C by long-chain bases (1989-03-28),

Title: Yusuf A. Hannun: Innovator in Ceramide Research

Introduction

Yusuf A. Hannun is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biochemistry, particularly in the study of ceramide and its implications in various diseases. With a total of 5 patents, his work has paved the way for new therapeutic approaches.

Latest Patents

Hannun's latest patents focus on inhibitors of ceramidase. The present invention relates, in general, to the bioeffector molecule ceramide and, in particular, to methods of effecting intracellular accumulation of ceramide. The invention further relates to methods of selecting compounds that inhibit alkaline ceramidase and that can be used to treat diseases or disorders associated with cell hyperplasia or dedifferentiation.

Career Highlights

Yusuf A. Hannun is affiliated with Duke University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on treating various health conditions linked to ceramide metabolism.

Collaborations

Some of his notable coworkers include Alicja Bielawska and Robert M. Bell. Their collaborative efforts have further advanced the research in ceramide and its therapeutic applications.

Conclusion

Yusuf A. Hannun's innovative research in ceramide inhibitors highlights his role as a key inventor in the field of biochemistry. His contributions continue to influence the development of new treatments for diseases associated with ceramide metabolism.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…